Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

403 ARTÍCULOS , VIENDO DEL 271 AL 285

Circulating Biomarker Panels in Alzheimer's Disease

Zafari S, Backes C, Meese E, Keller A.

Gerontology. 2015;61(6):497-503. doi: 10.1159/000375236. Epub 2015 Feb 25.

Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects

Wojsiat J, Prandelli C, Laskowska-Kaszub K, Martín-Requero A, Wojda U.

J Alzheimers Dis. 2015;46(2):329-50. doi: 10.3233/JAD-141977.

Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review

Strac DS, Muck-Seler D, Pivac N.

Psychiatr Danub. 2015 Mar;27(1):14-24.

[Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia]

Wiltfang J.

Ther Umsch. 2015 Apr;72(4):271-8. doi: 10.1024/0040-5930/a000675.

Neuroinflammation in Alzheimer's disease

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP.

Lancet Neurol. 2015 Apr;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5.

Analysis of optic disk color changes in Alzheimer's disease: a potential new biomarker

Bambo MP, Garcia-Martin E, Gutierrez-Ruiz F, Pinilla J, Perez-Olivan S, Larrosa JM, Polo V, Pablo L.

Clin Neurol Neurosurg. 2015 May;132:68-73. doi: 10.1016/j.clineuro.2015.02.016. Epub 2015 Mar 9.

Amyloid biomarkers in Alzheimer's disease

Blennow K, Mattsson N, Schöll M, Hansson O, Zetterberg H.

Trends Pharmacol Sci. 2015 May;36(5):297-309. doi: 10.1016/j.tips.2015.03.002. Epub 2015 Apr 1.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study

Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.

BMC Neurol. 2015 Apr 1;15:51. doi: 10.1186/s12883-015-0298-0.

Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update

Bradley-Whitman MA, Lovell MA.

Arch Toxicol. 2015 Jul;89(7):1035-44. doi: 10.1007/s00204-015-1517-6. Epub 2015 Apr 18.

Equivalence of kernel machine regression and kernel distance covariance for multidimensional phenotype association studies

Hua WY, Ghosh D.

Biometrics. 2015 Sep;71(3):812-20. doi: 10.1111/biom.12314. Epub 2015 May 1.

Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)

Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network.

Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

Rostgaard N, Waldemar G, Nielsen JE, Simonsen AH.

Dement Geriatr Cogn Disord. 2015;40(1-2):54-62. doi: 10.1159/000381828. Epub 2015 May 13.

[Biomarkers for early diagnosis of Alzheimer's disease]

Frederiksen KS, Hasselbalch S, Law I, Højgaard L, Waldemar G.

Ugeskr Laeger. 2015 Jun 8;177(24):V12140684.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias